patient-story-headshot-jeff

Jeff’s Story

Jeff, a NASA engineer and golf enthusiast, found himself working for the Apollo Space Program in Texas forty-five years ago. Jeff was involved in all of the Apollo/Saturn space launches up until the now infamous “Apollo 13” mission.

After his tenure with the Apollo Space Program, Jeff worked as a venture capitalist with various universities and companies to apply the technologies created for the space program to medicine and other parts of the economy. He worked with some of the major pioneering universities in the United States, including Stanford University where the first CyberKnife® System was created.

A few years ago, Jeff’s younger brother was diagnosed with prostate cancer and underwent surgery to remove the cancerous cells. Since his brother’s diagnosis, Jeff has been diligent in staying on top of his PSA testing. He continued to have a clean bill of health until a routine round of tests in November, 2008. Jeff’s PSA results came back higher than normal and after a biopsy determined he had a Gleason score of 6, he was diagnosed with early stage prostate cancer.

Jeff’s urologist at Overlook Hospital in Summit, New Jersey felt that surgery wasn’t a viable option for 72-year-old Jeff, and Jeff wasn’t interested in “watchful waiting”. Jeff was then offered three radiation treatment options: insert radioactive seeds into his prostate, conventional radiation therapy or CyberKnife radiosurgery.

“To me, I read these options as “slow, faster, fastest” as far as treatment times go,” Jeff said.

Wanting to get rid of the cancer as quickly as possible, Jeff opted for CyberKnife radiosurgery.

Jeff underwent five CyberKnife treatments during the course of a week. As there are minimal to no side effects with CyberKnife treatments, Jeff was able to maintain his daily routine during his treatments, including daily rounds of golf.

“The treatment was wonderful. No side effects, no problems, and, per my urologist, no cancer,” said Jeff.

Today, Jeff is cancer free and without the pressure of safely landing space shuttles, he is able to enjoy life and focus on improving his golf handicap.

As of the creation of this patient profile, Jeff found his CyberKnife treatment to be successful.

Share Your Story

Educating others about your experience with the CyberKnife® System can help others who face similar decisions about their own cancer treatment choices.

If you are interested in sharing your story, please fill out the form below and an Accuray representative will contact you.

Please note: Accuray is the manufacturer of the CyberKnife®, TomoTherapy®, and Radixact® Systems. As the manufacturer, we are unable to provide specific medical advice, view medical records, or schedule appointments.
Privacy Disclaimer: To protect your safety, please do not provide your personal or sensitive information, such as your medical history, on our websites. By entering any information on our websites, you understand and agree that such information will be transferred to Accuray Incorporated in the United States. Please read our Privacy Policy.
Important Safety Statement: Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death. Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient’s general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.